Literature DB >> 30848974

Periodontitis Is Associated with Chronic Obstructive Pulmonary Disease.

K Takeuchi1,2, K Matsumoto3, M Furuta1, S Fukuyama3, T Takeshita1,2, H Ogata3, S Suma1, Y Shibata1, Y Shimazaki1,4, J Hata5,6,7, T Ninomiya5,6, Y Nakanishi3, H Inoue8, Y Yamashita1.   

Abstract

Although they are known to share pathophysiological processes, the relationship between periodontitis and chronic obstructive pulmonary disease (COPD) is not fully understood. The aim of the present study was to test the hypothesis that periodontitis is associated with a greater risk of development of COPD, when smoking is taken into account. The analysis in a 5-y follow-up population-based cohort study was based on 900 community-dwelling Japanese adults (age: 68.8 ± 6.3 [mean ± SD], 46.0% male) without COPD aged 60 or older with at least 1 tooth. Participants were classified into 3 categories according to baseline periodontitis severity (no/mild, moderate, and severe). COPD was spirometrically determined by a fixed ratio of <0.7 for forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) and by FEV1/FVC below the lower limit of normal. Poisson regression was used to calculate the relative risk (RR) of developing COPD according to the severity of periodontitis. The population attributable fraction (PAF) was also calculated. During follow-up, 22 (2.4%) subjects developed COPD. Compared with no/mild periodontitis subjects, a significantly increased risk of COPD occurred among severe periodontitis subjects (RR = 3.55; 95% confidence interval [CI], 1.18 to 10.67), but no significant differences were observed between the no/mild and moderate categories (RR = 1.48; 95% CI, 0.56 to 3.90). After adjustment for potential confounders, including smoking intensity, the relationship between severe periodontitis and risk of COPD remained significant (RR = 3.51; 95% CI, 1.15 to 10.74). Likewise, there was a positive association of periodontitis severity with risk of COPD ( P for trend = 0.043). The PAF for COPD due to periodontitis was 22.6%. These data highlight the potential importance of periodontitis as a risk factor for COPD.

Entities:  

Keywords:  community dentistry; dental health survey(s); epidemiology; periodontal medicine; risk factor(s); tobacco

Mesh:

Year:  2019        PMID: 30848974     DOI: 10.1177/0022034519833630

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  8 in total

1.  Pulmonary disease and periodontal health: a meta-analysis.

Authors:  ZeSheng Wu; Chen Xiao; FangHui Chen; Yi Wang; ZhiDong Guo
Journal:  Sleep Breath       Date:  2022-02-05       Impact factor: 2.816

Review 2.  The role of Th17 cells: explanation of relationship between periodontitis and COPD?

Authors:  Jiaohong Liu; Yuanting Ouyang; Zhiyi Zhang; Siyi Wen; Yixing Pi; Ding Chen; Zhikang Su; Zitian Liang; Lvhua Guo; Yan Wang
Journal:  Inflamm Res       Date:  2022-07-04       Impact factor: 6.986

3.  Periodontal Status and Microbiologic Pathogens in Patients with Chronic Obstructive Pulmonary Disease and Periodontitis: A Case-Control Study.

Authors:  Xuan Zhou; Jitian Wang; Wenyan Liu; Xuan Huang; Yiqing Song; Zuomin Wang; Xingyuan Jia
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-09-03

4.  Periodontal Disease and Age-Related Macular Degeneration: A Meta-Analysis of 112,240 Participants.

Authors:  Xuewen Lv; Weiqi Li; Zhiyu Fang; Xiaofei Xue; Chunling Pan
Journal:  Biomed Res Int       Date:  2020-09-28       Impact factor: 3.411

5.  Effect of periodontal therapy on COPD outcomes: a systematic review.

Authors:  Ioulianos Apessos; Athanasios Voulgaris; Michalis Agrafiotis; Dimitrios Andreadis; Paschalis Steiropoulos
Journal:  BMC Pulm Med       Date:  2021-03-18       Impact factor: 3.317

6.  Oral Pathogen Fusobacterium nucleatum Coaggregates With Pseudomonas aeruginosa to Modulate the Inflammatory Cytotoxicity of Pulmonary Epithelial Cells.

Authors:  Qian Li; Hongyan Wang; Lisi Tan; Shuwei Zhang; Li Lin; Xiaolin Tang; Yaping Pan
Journal:  Front Cell Infect Microbiol       Date:  2021-03-19       Impact factor: 5.293

7.  Fusobacterium nucleatum exacerbates chronic obstructive pulmonary disease in elastase-induced emphysematous mice.

Authors:  Ryuta Suzuki; Noriaki Kamio; Tadayoshi Kaneko; Yoshiyuki Yonehara; Kenichi Imai
Journal:  FEBS Open Bio       Date:  2022-01-30       Impact factor: 2.693

8.  Molecular Mechanism of Xixin-Ganjiang Herb Pair Treating Chronic Obstructive Pulmonary Disease-Integrated Network Pharmacology and Molecular Docking.

Authors:  Ping Huang; Tao Huang; Deshun Li; Lintao Han; Zhenxiang Zhou; Fang Huang; Jingjing Li; Jiajia Wu; Yan Ye; Qiong Wang; Bailu Duan
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-10       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.